Health and Fitness Health and Fitness
Wed, February 25, 2009
[ Wed, Feb 25th 2009 ] - Market Wire
Zacks Bull and Bear of the Day Highlights: Onyx P .. Bristol Myers, Biogen Idec and Strayer Education
[ Wed, Feb 25th 2009 ] - Market Wire
A.P. Pharma Appoints John B. Whelan as Chief Financial Officer
[ Wed, Feb 25th 2009 ] - Market Wire
Zacks Industry Outlook Highlights: Immucor
[ Wed, Feb 25th 2009 ] - Market Wire
Elan Announces Further Alignment of Resources as Part of On-Going Strategic Review Process
Tue, February 24, 2009
[ Tue, Feb 24th 2009 ] - Market Wire
Luminex Corporation Announces the Release of xPONENT® 3.1 Software
[ Tue, Feb 24th 2009 ] - Market Wire
Cerus Announces Marketing Authorization Granted to Largest Region of German Red Cross
[ Tue, Feb 24th 2009 ] - Market Wire
Harvard Pilgrim Health Care Initiates Coverage for Microvolt T-Wave Alternans Testing
[ Tue, Feb 24th 2009 ] - Market Wire
HemaCare Corporation: HemaCare Reports Record 4th Quarter and 2008 Revenues
[ Tue, Feb 24th 2009 ] - Market Wire
Marshall Edwards, Inc.: Yale Researchers Present .. iol Clinical Trial in Prostate Cancer Patients at
[ Tue, Feb 24th 2009 ] - Market Wire
Allana Resources Inc.: Allana Resources Exhibits at PDAC, Booth 2529
[ Tue, Feb 24th 2009 ] - Market Wire
Free Electronic Prescribing Service Now Available to San Antonio Physicians
[ Tue, Feb 24th 2009 ] - Market Wire
Health Net Announces New Enterprise-Wide Quality Office
[ Tue, Feb 24th 2009 ] - Market Wire
Assisted Living Concepts, Inc.: Assisted Living C .. Fourth Quarter and Full Year Results -- Solid Fou
[ Tue, Feb 24th 2009 ] - Market Wire
St. Jude Medical Receives Australian TGA Regulato .. for the World?s Smallest and Longest-Lasting Rec
[ Tue, Feb 24th 2009 ] - Market Wire
Optimer Pharmaceuticals Announces Positive Result .. f Prulifloxacin for Infectious Diarrhea in Travel
[ Tue, Feb 24th 2009 ] - Market Wire
Cypress Bioscience Inc.: Cypress Bioscience, Inc. .. ne Technology Platform From Cellatope Corporation
[ Tue, Feb 24th 2009 ] - Market Wire
CPEX Pharmaceuticals Initiates Phase II Clinical Trial of Nasulin®
[ Tue, Feb 24th 2009 ] - Market Wire
Samenvatting: Biogen Idec benoemt Michael Lytton .. executive vice president van Business Development
[ Tue, Feb 24th 2009 ] - Market Wire
Salix Pharmaceuticals Announces 4Q2008 and FY2008 Financial Results Conference Call and Webcast
[ Tue, Feb 24th 2009 ] - Market Wire
Resumen: Biogen Idec nombra a Michael Lytton vicepresidente ejecutivo de desarrollo empresarial
[ Tue, Feb 24th 2009 ] - Market Wire
Bioject Enters into a Collaborative Research Agre .. IAVI for the Delivery of an HIV Vaccine Candidate
[ Tue, Feb 24th 2009 ] - Market Wire
Acorda Therapeutics Reports Fourth Quarter and Full Year 2008 Financial Results
Mon, February 23, 2009
[ Mon, Feb 23rd 2009 ] - Market Wire
Genentech Announces March 2, 2009 Webcast of Investment Community Meeting
[ Mon, Feb 23rd 2009 ] - Market Wire
Celldex to Report Fourth Quarter and Fiscal 2008 Financial Results on February 27, 2009
[ Mon, Feb 23rd 2009 ] - Market Wire
GTC Biotherapeutics to Host Fourth Quarter and Ye .. ngs Call and Webcast on Friday, February 27, 2009
[ Mon, Feb 23rd 2009 ] - Market Wire
MDRNA, Inc.: MDRNA Successfully Silences Gene Tar .. ts in Animal Models Using Novel UsiRNA Constructs
[ Mon, Feb 23rd 2009 ] - Market Wire
Medtronic to Acquire CoreValve, Inc.
[ Mon, Feb 23rd 2009 ] - Market Wire
Medtronic Acquires Ventor Technologies Ltd.
[ Mon, Feb 23rd 2009 ] - Market Wire
Harte Gold Corp.: Harte Announces Change of Auditor
[ Mon, Feb 23rd 2009 ] - Market Wire
Aradigm Announces $4.1 Million Registered Direct Offering
[ Mon, Feb 23rd 2009 ] - Market Wire
Flamel Technologies Announces Appointment of Jeffery S. Vick as Chief Business Officer
[ Mon, Feb 23rd 2009 ] - Market Wire
CytRx?s Arimoclomol to be Administered in a Phase .. l Trial in a Subset of Patients with Familial ALS
[ Mon, Feb 23rd 2009 ] - Market Wire
Editorial Article in the Clinical Chemistry Highl .. n Optimization of the Non-Invasive Transrenal DNA
[ Mon, Feb 23rd 2009 ] - Market Wire
Celsion to Report Clinical Trial Update of Thermo .. Breast Cancer Study at the Society for Thermal Me
[ Mon, Feb 23rd 2009 ] - Market Wire
Optimer Pharmaceuticals Appoints Industry Veteran .. s Chief Scientific Officer and Peter E. Grebow to
[ Mon, Feb 23rd 2009 ] - Market Wire
GTx Initiates Phase I Clinical Trial for GTx-758, .. ng Hormone Inhibitor for Advanced Prostate Cancer
[ Mon, Feb 23rd 2009 ] - Market Wire
Japanese Researchers Find CSA-13 May Be Useful fo .. reatment of Dental Caries and Periodontal Disease
[ Mon, Feb 23rd 2009 ] - Market Wire
Amedisys to Host Investor Day
[ Mon, Feb 23rd 2009 ] - Market Wire
CytoCore Signs Agreement to Sell Synermed?s General Cytology Preservative with SoftPAP
[ Mon, Feb 23rd 2009 ] - Market Wire
Cardima Completes Second Atrial Fibrillation Training Session in Thailand
Sun, February 22, 2009
[ Sun, Feb 22nd 2009 ] - Market Wire
Astellas Pharma Issues Statement Regarding CV Therapeutics Rejection of All-Cash Proposal
Fri, February 20, 2009
[ Fri, Feb 20th 2009 ] - Market Wire
ZOLL Medical Corporation Announces Agreement To Purchase Assets of Alsius Corporation
[ Fri, Feb 20th 2009 ] - Market Wire
Midland Exploration Inc.: Midland Exploration Grants 420,000 Stock Options
[ Fri, Feb 20th 2009 ] - Market Wire
Harte Gold Corp.: Harte Gold Corp. Grant of Options and Issue of Shares for Debt
[ Fri, Feb 20th 2009 ] - Market Wire
PDL BioPharma: PDL BioPharma to Host Fourth-Quart .. inancial Results Conference Call on March 2, 2009
[ Fri, Feb 20th 2009 ] - Market Wire
Chemed Corporation to Present at Baird?s 2009 Business Solutions Conference
[ Fri, Feb 20th 2009 ] - Market Wire
Study of Genzyme Oral Compound for Gaucher Disease Meets Primary Endpoint
[ Fri, Feb 20th 2009 ] - Market Wire
Humana Names Paul Kusserow Senior Vice President and Chief Strategy Officer
[ Fri, Feb 20th 2009 ] - Market Wire
Orthovita to Present at the Canaccord Adams Musculoskeletal Conference
[ Fri, Feb 20th 2009 ] - Market Wire
ARIAD Announces $24.3 Million Registered Direct Financing
[ Fri, Feb 20th 2009 ] - Market Wire
Ophthalmic Imaging Systems Comments on Potential .. timulus Package on Electronic Health Records Mark
[ Fri, Feb 20th 2009 ] - Market Wire
Targanta Enters into Memorandum of Understanding to Resolve Shareholder Lawsuit
[ Fri, Feb 20th 2009 ] - Market Wire
EnteroMedics Announces $15.89 Million Private Placement
[ Fri, Feb 20th 2009 ] - Market Wire
StemCells, Inc. Comments on PLoS Medicine Article Concerning Cell Transplants in Russia
[ Fri, Feb 20th 2009 ] - Market Wire
EPIX Pharmaceuticals to Present Preclinical Data for Two Programs at Keystone Symposia
[ Fri, Feb 20th 2009 ] - Market Wire
WellCare Responding to Concerns Raised by Centers for Medicare & Medicaid Services
[ Fri, Feb 20th 2009 ] - Market Wire
Strategic Re-alignment Continues - Fourth Quarter 2008 Financial Results Reported
Thu, February 19, 2009
[ Thu, Feb 19th 2009 ] - Market Wire
La Jolla Pharmaceutical Company Announces Reduction in Workforce and Evaluates Strategic Options
[ Thu, Feb 19th 2009 ] - Market Wire
Metropolitan Health Networks to Announce Fourth Quarter and Fiscal 2008 Results
[ Thu, Feb 19th 2009 ] - Market Wire
Genzyme Receives Positive Opinion on Myozyme from CHMP
[ Thu, Feb 19th 2009 ] - Market Wire
Wound Management Technologies, Inc.: OTC Financia .. te Profile on Wound Management Technologies, Inc.
[ Thu, Feb 19th 2009 ] - Market Wire
Medtronic Board Approves Fourth Quarter Cash Dividend
[ Thu, Feb 19th 2009 ] - Market Wire
BioMimetic Therapeutics, Inc. to Highlight Pre-Cl .. and Clinical Activities at ORS and AAOS Meetings
[ Thu, Feb 19th 2009 ] - Market Wire
San Anton Resource Corporation: San Anton Announces Cerro Del Gallo Project Update
[ Thu, Feb 19th 2009 ] - Market Wire
XELR8 Holdings, Inc.: XELR8 Holdings, Inc. Retain .. LC to Implement Global Investor Relations Program
[ Thu, Feb 19th 2009 ] - Market Wire
AVI BioPharma, Inc.: AVI BioPharma Announces Trea .. temic Clinical Trial of AVI-4658 for Treatment of
[ Thu, Feb 19th 2009 ] - Market Wire
Seattle Genetics Initiates Pivotal Trial of SGN-35 for Hodgkin Lymphoma
[ Thu, Feb 19th 2009 ] - Market Wire
XELR8 Holdings, Inc.: XELR8 Holdings Expands Affiliation With Major Medical Center
[ Thu, Feb 19th 2009 ] - Market Wire
Depomed, Inc. to Announce Fourth Quarter and Year-End 2008 Financial Results on March 5, 2009
[ Thu, Feb 19th 2009 ] - Market Wire
MiddleBrook Pharmaceuticals Schedules Conference .. 08 Fourth Quarter and Full-Year Financial Results
[ Thu, Feb 19th 2009 ] - Market Wire
Enzon Reports 2008 Results
[ Thu, Feb 19th 2009 ] - Market Wire
Invacare Corporation Announces Appointment of Dale C. LaPorte to Board of Directors
[ Thu, Feb 19th 2009 ] - Market Wire
Forensic DNA Shown to Lower Crime Rates and Decrease Property Loss
[ Thu, Feb 19th 2009 ] - Market Wire
Antigenics Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights
Wed, February 18, 2009
[ Wed, Feb 18th 2009 ] - Market Wire
Resumen: Estudio revelador publicado en The Lance .. ® de Celgene demuestra supervivencia sin preceden
[ Wed, Feb 18th 2009 ] - Market Wire
Remedent, Inc.: Remedent Sets Third Fiscal Quarte .. ce Call for Tuesday, February 24 at 11:00 a.m. ET
[ Wed, Feb 18th 2009 ] - Market Wire
PDL BioPharma: PDL BioPharma Receives Nasdaq Notice Related to Audit Committee Composition
[ Wed, Feb 18th 2009 ] - Market Wire
USANA Recognized as Newest Member of the Council for Responsible Nutrition
[ Wed, Feb 18th 2009 ] - Market Wire
Orthofix International to Participate in Canaccord Adams Musculoskeletal Conference
[ Wed, Feb 18th 2009 ] - Market Wire
DelSite, Inc: DelSite Announces Intention to Lice .. nufacturing Rights, Fields of Use and Territories
[ Wed, Feb 18th 2009 ] - Market Wire
FONAR Corporation: FONAR Reports Profit and 2nd Quarter Fiscal 2009 Financial Results
[ Wed, Feb 18th 2009 ] - Market Wire
ReGen Biologics Initiates Training Program for U.S. Surgeons
[ Wed, Feb 18th 2009 ] - Market Wire
Alkermes Announces Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
[ Wed, Feb 18th 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. h Quarter and Full Year 2008 Financial Results, a
[ Wed, Feb 18th 2009 ] - Market Wire
Allion Healthcare Announces Date of Fourth Quarter 2008 Financial Results and Conference Call
[ Wed, Feb 18th 2009 ] - Market Wire
Dyax Corp. to Host Fourth Quarter and Year End 2008 Earnings Call and Webcast
[ Wed, Feb 18th 2009 ] - Market Wire
IsoRay, Inc. Announces Distribution Agreement with BrachySciences
[ Wed, Feb 18th 2009 ] - Market Wire
GTx Announces Toremifene 80 mg NDA Accepted for Review by FDA
[ Wed, Feb 18th 2009 ] - Market Wire
Emeritus Announces Resignation of Chief Operating Officer
[ Wed, Feb 18th 2009 ] - Market Wire
Incyte Reports Fourth Quarter and Year-End 2008 F .. ancial Results; Announces 2009 Financial Guidance
[ Wed, Feb 18th 2009 ] - Market Wire
High-Throughput Genotyping of AML Patients for a .. eptor May Significantly Improve Treatment Outcome
Tue, February 17, 2009
[ Tue, Feb 17th 2009 ] - Market Wire
Teva Invites Public to Listen to Investor & Analyst Meeting Webcast
[ Tue, Feb 17th 2009 ] - Paula Catchpole
New Study From Plastic and Reconstructive Surgery Journal Shows How Not To Look Old.
[ Tue, Feb 17th 2009 ] - Market Wire
Remedent, Inc.: Remedent Engages Liolios Group to Lead New Investor Relations Program
[ Tue, Feb 17th 2009 ] - Market Wire
Quova, Inc.: Quova Provides Wi-Fi Triangulation Data to Absolute Software
[ Tue, Feb 17th 2009 ] - Market Wire
Depomed Initiates Phase I Trial for DM-1992 Progr .. lowing Positive Results of Preclinical Studies Sp
[ Tue, Feb 17th 2009 ] - Market Wire
AVANIR Announces Fiscal 2009 First Quarter Financial Results
[ Tue, Feb 17th 2009 ] - Market Wire
Alnylam to Webcast Conference Call Discussing Fourth Quarter and 2008 Financial Results
[ Tue, Feb 17th 2009 ] - Market Wire
Affymax Announces $42 Million Private Placement
[ Tue, Feb 17th 2009 ] - Market Wire
BioSante Pharmaceuticals, Inc. Presents LibiGel® .. nical and Market Information at ISSWSH Conference
[ Tue, Feb 17th 2009 ] - Market Wire
St. Jude Medical Welcomes Introduction of Legislation to Help People Suffering From Pain
[ Tue, Feb 17th 2009 ] - Market Wire
Sepracor Announces Tender Offer for 0% Convertible Senior Subordinated Notes Due 2024
[ Tue, Feb 17th 2009 ] - Market Wire
Phase 1 Trial Begins for Investigational New Drug for MDR Gram-negative Infections
[ Tue, Feb 17th 2009 ] - Market Wire
Natus Medical to Hold 2008 Fourth Quarter Financial Results Conference Call on February 26
[ Tue, Feb 17th 2009 ] - Market Wire
California Hospital Implements ZOLL AutoPulse
[ Tue, Feb 17th 2009 ] - Market Wire
Inspire Announces Date for Conference Call and We .. urth Quarter and Full Year 2008 Financial Results
[ Tue, Feb 17th 2009 ] - Market Wire
Acorda Therapeutics to Host Conference Call to Re .. Year 2008 Financial Results on February 24, 2009
[ Tue, Feb 17th 2009 ] - Market Wire
GTX Reports Fourth Quarter and Year End 2008 Results
[ Tue, Feb 17th 2009 ] - Market Wire
Zacks Bull & Bear of the Day Highlights: Baxter I .. nal, Marriott International, UDR, AIV and Vornado
Mon, February 16, 2009
[ Mon, Feb 16th 2009 ] - Market Wire
Constellation Software Inc.: Constellation Softwa .. Call to Discuss Fourth Quarter and Annual Results
[ Mon, Feb 16th 2009 ] - Market Wire
Wright Medical Group, Inc. to Participate in The Canaccord Adams Musculoskeletal Conference
[ Mon, Feb 16th 2009 ] - Market Wire
LifeVantage Corporation Announces the Addition of .. ing Network Marketing Distributors and Executives
[ Mon, Feb 16th 2009 ] - Market Wire
Applied Biosystems and Baylor College of Medicine .. ons to First Data Release of 1000 Genomes Project
Fri, February 13, 2009
[ Fri, Feb 13th 2009 ] - Market Wire
Signature Eyewear Reports Net Income for 2008
[ Fri, Feb 13th 2009 ] - Market Wire
Hypertension Diagnostics: Hypertension Diagnostics Announces FY 2009 Second Quarter Results
[ Fri, Feb 13th 2009 ] - Market Wire
Genta Incorporated Announces Fourth Quarter and Y .. d 2008 Financial Results and Corporate Highlights
[ Fri, Feb 13th 2009 ] - Market Wire
Orthovita to Present at the Roth Capital Partners 21st Annual Growth Stock Conference
[ Fri, Feb 13th 2009 ] - Market Wire
Schaeffer's Street Stories: Cephalon Inc. Struggles with Staunch Technical Resistance
[ Fri, Feb 13th 2009 ] - Market Wire
Amarillo Biosciences, Inc.: Amarillo Biosciences .. o Enroll 165 Patient Phase 2 Hepatitis C Trial in
[ Fri, Feb 13th 2009 ] - Market Wire
Enzon to Release Fourth Quarter 2008 Earnings on .. y 19, 2009; Conference Call and Webcast to Follow
[ Fri, Feb 13th 2009 ] - Market Wire
Universittsklinikum Heidelberg untersucht fortschrittliche Tomotherapie-Bestrahlungstechnik
[ Fri, Feb 13th 2009 ] - Market Wire
MDRNA, Inc.: MDRNA, Inc. Announces Licensing Agreement With Roche
[ Fri, Feb 13th 2009 ] - Market Wire
Bond Laboratories, Inc. Announces the Appointment .. keting Executives as President and Executive Vice
[ Fri, Feb 13th 2009 ] - Market Wire
Mannatech Presents Scientific Posters at Scripps .. icine?s 6th Annual Natural Supplements Conference
[ Fri, Feb 13th 2009 ] - Market Wire
Pioneer Behavioral Health: PHC Reports Second Quarter Fiscal 2009 Results
[ Fri, Feb 13th 2009 ] - Market Wire
Geron Corporation Announces Pricing of Common Stock Offering
[ Fri, Feb 13th 2009 ] - Market Wire
Adrenalina Discloses Its Four Nominees for Election to the Pacific Sunwear Board
[ Fri, Feb 13th 2009 ] - Market Wire
Cypress Bioscience, Inc.: Cypress Bioscience, Inc .. l Partners 21st Annual OC Growth Stock Conference
[ Fri, Feb 13th 2009 ] - Market Wire
Electro-Optical Sciences, Inc.: Electro-Optical S .. op-Line Results From Landmark MelaFind(R) Pivotal
[ Fri, Feb 13th 2009 ] - Market Wire
Obagi Medical Products to Report Fourth Quarter a .. ial Results and Host a Conference Call on March 5
Thu, February 12, 2009
[ Thu, Feb 12th 2009 ] - Market Wire
Osiris Announces Fourth Quarter and Full Year 2008 Financial Results Conference Call
[ Thu, Feb 12th 2009 ] - Market Wire
Theravance, Inc.: Theravance Reports Fourth Quarter and Full Year 2008 Results
[ Thu, Feb 12th 2009 ] - Market Wire
Targacept Reports Fourth Quarter and 2008 Financial Results
[ Thu, Feb 12th 2009 ] - Market Wire
Biovail Announces Fourth-Quarter 2008 Earnings Release, Conference-Call Details
[ Thu, Feb 12th 2009 ] - Market Wire
I-Flow Will Present at the Roth Capital Partners .. nce Wednesday, February 18, 2009 at 4:00 p.m. PST
[ Thu, Feb 12th 2009 ] - Market Wire
InSight Health Services Holdings Corp. to Host Second Quarter Fiscal 2009 Results Conference Call
[ Thu, Feb 12th 2009 ] - Market Wire
American Shared Hospital Services to Develop Prot .. iation Therapy Facility in San Francisco Bay Area
[ Thu, Feb 12th 2009 ] - Market Wire
Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by FDA
[ Thu, Feb 12th 2009 ] - Market Wire
Shareholder Group Led by Adrenalina Announces Nom .. didates for Election to the Pacific Sunwear Board
[ Thu, Feb 12th 2009 ] - Market Wire
Curis Announces Genentech?s Initiation of Pivotal .. rial of GDC-0449 in Advanced Basal Cell Carcinoma
[ Thu, Feb 12th 2009 ] - Market Wire
Syneron Medical Ltd.: Syneron Reports Fourth Quarter and Full Year 2008 Results
[ Thu, Feb 12th 2009 ] - Market Wire
BioDelivery Sciences to Present at the ROTH Capit .. l Partners 21st Annual OC Growth Stock Conference
[ Thu, Feb 12th 2009 ] - Market Wire
Antigenics to Report Fourth Quarter and Year-End .. s on February 19, 2009; Conference Call to Follow
[ Thu, Feb 12th 2009 ] - Market Wire
Merck & Co., Inc. Acquires Biologic Manufacturing .. pmental Follow-on Biologics Portfolio from Insmed
[ Thu, Feb 12th 2009 ] - Market Wire
Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction
[ Thu, Feb 12th 2009 ] - Market Wire
Spectranetics to Hold 2008 Fourth Quarter Financial Results Conference Call on February 19
[ Thu, Feb 12th 2009 ] - Market Wire
Emergent BioSolutions anuncia que BioThrax (Vacin .. Antraz) recebe autorizao de comercializao na ndia
Wed, February 11, 2009
[ Wed, Feb 11th 2009 ] - Market Wire
Novelos Therapeutics and Mundipharma Sign Exclusive Collaboration Agreement in Europe and Japan
[ Wed, Feb 11th 2009 ] - Market Wire
Zila Completes First Phase of Global Marketing In .. or Oral Cancer Screening Product, ViziLite® Plus
[ Wed, Feb 11th 2009 ] - Market Wire
Pacific Biometrics, Inc.: Pacific Biometrics to H .. r Conference Call on Wednesday, February 18, 2009
[ Wed, Feb 11th 2009 ] - Market Wire
Adeona Pharmaceuticals, Inc.: Adeona Pharmaceutic .. nce of Claims Relating to Heat Shock Protein dnaJ
[ Wed, Feb 11th 2009 ] - Market Wire
BioElectronics Corporation: BioElectronics Announces Major Shipments
[ Wed, Feb 11th 2009 ] - Market Wire
Lpath, Inc.: Category Leader Lpath Establishes Key 2009 Goals
[ Wed, Feb 11th 2009 ] - Market Wire
Angeion to Announce 2009 First-Quarter Results on Wednesday, February 25
[ Wed, Feb 11th 2009 ] - Market Wire
Orthofix International and The Musculoskeletal Tr .. Accelerate Release Date for Trinity® Evolution"
[ Wed, Feb 11th 2009 ] - Market Wire
Genta Submits Randomized Study of Tesetaxel in Pa .. ric Cancer to FDA for Special Protocol Assessment
[ Wed, Feb 11th 2009 ] - Market Wire
Alnylam and Collaborators Publish New Pre-Clinica .. ivo Efficacy of Systemically Delivered RNAi Thera
[ Wed, Feb 11th 2009 ] - Market Wire
Professor John F. Thompson to Present at the Sixt .. Melanoma and Other Cutaneous Malignancies on Marc
[ Wed, Feb 11th 2009 ] - Market Wire
POZEN Announces February 25, 2009 Webcast of Fourth Quarter and Year End 2008 Results
[ Wed, Feb 11th 2009 ] - Market Wire
Salix Pharmaceuticals to Present at Roth Conference
[ Wed, Feb 11th 2009 ] - Market Wire
Compugen Ltd. Reports Fourth Quarter and Year-End 2008 Financial Results
[ Wed, Feb 11th 2009 ] - Market Wire
Gilead pr©sente des donn©es montrant l?activit© d?amplification pharmacocin©tique du GS 9350
[ Wed, Feb 11th 2009 ] - Market Wire
Zacks Industry Outlook Highlights: Pfizer, Eli Lilly, Merck, Sanofi and Schering-Plough
[ Wed, Feb 11th 2009 ] - Market Wire
Micrus Endovascular Initiates VISSIT Trial with Pharos Vitesse Balloon Expandable Stent
Tue, February 10, 2009
[ Tue, Feb 10th 2009 ] - Market Wire
Daxor Corp.: Daxor Announces Publication in The A .. oncerning Blood Volume in Critically Ill Surgical
[ Tue, Feb 10th 2009 ] - Market Wire
Significant Shareholder Calls upon Enzon to Immed .. tely Add Two Candidates to the Board of Directors
[ Tue, Feb 10th 2009 ] - Market Wire
Tenet Announces Definitive Agreement to Sell USC University Hospital
[ Tue, Feb 10th 2009 ] - Market Wire
NeuroMetrix, Inc. Reports Total Revenues of $7.2 Million for the Fourth Quarter of 2008
[ Tue, Feb 10th 2009 ] - Market Wire
Enzon Announces IND Acceptance for Its Survivin Antagonist
[ Tue, Feb 10th 2009 ] - Market Wire
Oculus Innovative Sciences to Present at the Roth .. l Partners 21st Annual OC Growth Stock Conference
[ Tue, Feb 10th 2009 ] - Market Wire
Cougar Biotechnology Announces Agreement with FDA .. nt for Phase III Trial of CB7630 (Abiraterone Ace
[ Tue, Feb 10th 2009 ] - Market Wire
Alnylam Receives Grant of New Patent Broadly Covering RNAi Therapeutics
[ Tue, Feb 10th 2009 ] - Market Wire
Synta Pharmaceuticals Announces First Patient Tre .. Elesclomol Monotherapy Solid Tumor Clinical Study
[ Tue, Feb 10th 2009 ] - Market Wire
Curis Reports Fourth Quarter and Year-End 2008 Financial Results
[ Tue, Feb 10th 2009 ] - Market Wire
Reflect Scientific: Reflect Scientific, Inc. Receives a $200,000 Order for CatPro 5000 System
[ Tue, Feb 10th 2009 ] - Market Wire
Inspire Elects Alan F. Holmer to Board of Directors
[ Tue, Feb 10th 2009 ] - Market Wire
VIVUS Initiates Second Pivotal Phase 3 Trial of Avanafil for Treatment of Erectile Dysfunction
[ Tue, Feb 10th 2009 ] - Market Wire
Natus to Present at the Roth Capital Partners 21st Annual Growth Stock Conference
[ Tue, Feb 10th 2009 ] - Market Wire
Cubist Plans to Commence Patent Infringement Liti .. nteral Medicines, Inc. In Response To ANDA filing
[ Tue, Feb 10th 2009 ] - Market Wire
Dyax and Fovea Sign Development and Commercializa .. ion Agreement for DX-88 in Ophthalmic Indications
[ Tue, Feb 10th 2009 ] - Market Wire
Bioject Extends Supply Agreement with Ferring Pharmaceuticals, Inc.
Mon, February 9, 2009
[ Mon, Feb 09th 2009 ] - Market Wire
Fachmagazin Lancet Neurology verffentlicht Daten, .. ndelte MS-Patienten zwei Jahre lang frei von Kran
[ Mon, Feb 09th 2009 ] - Market Wire
Clinical Data Announces Third Quarter Fiscal 2009 Financial Results
[ Mon, Feb 09th 2009 ] - Market Wire
Orthofix International Raises Concerns About Another Ramius Nominee for Orthofix Board
[ Mon, Feb 09th 2009 ] - Market Wire
Allana Resources Inc.: Allana Resources Initiates .. nnaissance Surveys on Potash Resource in Ethiopia
[ Mon, Feb 09th 2009 ] - Market Wire
Oculus Innovative Sciences? Security Holders Exer .. any as Result of Recently Announced Strategic Inv
[ Mon, Feb 09th 2009 ] - Market Wire
Curis Announces Collaborative Agreement between G .. nentech and National Cancer Institute on GDC-0449
[ Mon, Feb 09th 2009 ] - Market Wire
Synovis Life Technologies to Present at 21st Annu .. Capital Partners Growth Stock Conference Feb. 18
[ Mon, Feb 09th 2009 ] - Market Wire
Ligand Earns $1 Million Milestone Payment on Progress of Drug Candidate for Alzheimer?s Disease
[ Mon, Feb 09th 2009 ] - Market Wire
Oculus Innovative Sciences Announces Fiscal Third .. and Corporate Update Release and Conference Call
[ Mon, Feb 09th 2009 ] - Market Wire
Synta Pharmaceuticals Names Dr. Vojo Vukovic, Vice President, Clinical Research
[ Mon, Feb 09th 2009 ] - Market Wire
Theragenics Corporation® Announces Schedule for Fourth Quarter and Year-End 2008 Conference Call
[ Mon, Feb 09th 2009 ] - Market Wire
Compugen Appoints Dov Hershberg Chairman of the Board
[ Mon, Feb 09th 2009 ] - Market Wire
Inhibitex Completes Phase I Clinical Trials for F .. ad HCV Compounds for Advanced Preclinical Studies
[ Mon, Feb 09th 2009 ] - Market Wire
Dynavax Announces Receipt of Communication from the U.S. FDA on HEPLISAVTM Hepatitis B Vaccine
[ Mon, Feb 09th 2009 ] - Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Issues G .. hrough to Profitability for the Full Year of 2009
[ Mon, Feb 09th 2009 ] - Market Wire
EPIX Pharmaceuticals Provides Update on NASDAQ Listing Status
[ Mon, Feb 09th 2009 ] - Market Wire
Zacks Bull & Bear of the Day Highlights: Biogen Idec, CEMEX, Ford, Tata Motors and Carmike Cinemas
Sun, February 8, 2009
[ Sun, Feb 08th 2009 ] - Market Wire
Riassunto: Nei pazienti affetti da sclerosi multi .. malattia non manifesta attivit per due anni, seco
[ Sun, Feb 08th 2009 ] - Market Wire
MS Patients Treated with TYSABRI® Remain Free of .. s, According to Data Published in the Lancet Neur

Inspire Announces Date for Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2008 Financial Results


//health-fitness.news-articles.net/content/2009/ .. uarter-and-full-year-2008-financial-results.html
Published in Health and Fitness on Tuesday, February 17th 2009 at 4:32 GMT, Last Modified on 2009-02-17 04:33:26 by Market Wire   Print publication without navigation


DURHAM, N.C.--([ BUSINESS WIRE ])--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that it plans to report fourth quarter and full year 2008 financial results on Tuesday, March 3, 2009 before the market opens. Inspire's President and CEO, Christy L. Shaffer, Ph.D., and Executive Vice President and CFO, Thomas R. Staab, II, will host a conference call and live webcast on Tuesday, March 3, 2009 at 10:00 a.m. ET.

To access the conference call, U.S. participants may call (877) 648-7970 and international participants may call (706) 902-0415. The conference ID number is 85896375. A live webcast and replay of the call will be available on Inspire's website at [ www.inspirepharm.com ]. A telephone replay of the conference call will be available until March 17, 2009. To access this replay, U.S. participants may call (800) 642-1687 and international participants may call (706) 645-9291. The conference ID number is 85896375.

About Inspire

Inspire is a biopharmaceutical company dedicated to discovering, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. Inspire is currently developing products for dry eye, cystic fibrosis and glaucoma. Inspire employs a U.S. sales force for the promotion of AzaSite® (azithromycin ophthalmic solution) 1% for bacterial conjunctivitis and Elestat® (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis. Elestat is a registered trademark owned by Allergan, Inc. AzaSite is a registered trademark owned by InSite Vision Incorporated. For more information, visit [ www.inspirepharm.com ].


Publication Contributing Sources